Eagle Bay Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48
| Closed | -$471 | – | 346 |
|
|
2024
Q4 | $471 | Hold |
48
| – | – | ﹤0.01% | 963 |
|
|
2024
Q3 | $391 | Sell |
48
-1
| -2% | -$8 | ﹤0.01% | 1318 |
|
|
2024
Q2 | $654 | Hold |
49
| – | – | ﹤0.01% | 953 |
|
|
2024
Q1 | $2.27K | Hold |
49
| – | – | ﹤0.01% | 865 |
|
|
2023
Q4 | $3.31K | Hold |
49
| – | – | ﹤0.01% | 691 |
|
|
2023
Q3 | $3.54K | Hold |
49
| – | – | ﹤0.01% | 710 |
|
|
2023
Q2 | $3.64K | Hold |
49
| – | – | ﹤0.01% | 707 |
|
|
2023
Q1 | $2.6K | Hold |
49
| – | – | ﹤0.01% | 730 |
|
|
2022
Q4 | $3.31K | Buy |
49
+4
| +9% | +$270 | ﹤0.01% | 700 |
|
|
2022
Q3 | $6K | Hold |
45
| – | – | ﹤0.01% | 651 |
|
|
2022
Q2 | $4.31K | Buy |
+45
| New | +$4.31K | ﹤0.01% | 724 |
|
|
2022
Q1 | – | Sell |
-23
| Closed | -$8K | – | 467 |
|
|
2021
Q4 | $8K | Buy |
23
+10
| +77% | +$3.48K | 0.01% | 701 |
|
|
2021
Q3 | $8K | Buy |
+13
| New | +$8K | ﹤0.01% | 732 |
|